Erlotinib

Overview

Erlotinib is an EGFR inhibitor with IC50 of 2 nM, >1000-fold more sensitive for EGFR than human c-Src or v-Abl. Erlotinib has been indicated for non-small cell lung cancer (NSCLC) and pancreatic cancer therapy.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cardiovascular and blood system | EGFR

Product Information

• Catalog No.: B0084-086248
• CAS No.: 183321-74-6
• Molecular Formula: C22H23N3O4
• Molecular Weight: 393.44
• Purity: >98%

Source

Original product source